Received Mar 2, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | jx5k9 | IM / LA |
Site: Bruising at Injection Site-Mild, Additional Details: Patient did not react at the pharmacy, weeks apart from when injection given. We were unable to recieve information regarding the interaction patient recieved from hospital, Other Vaccines: VaccineTypeBrand: Arexvy RSV; Manufacturer: Glaxosmithkline biologicals; LotNumber: ; Route: im; BodySite: l; Dose: ; VaxDate: UNKNOWN